43% COST SAVINGS 1 WITH TAUROLOCK UROKINASE 25.000 IU The antimicrobial efficacy of TauroLockTM-U25.000 Catheter Locking Solution (CLS) means that clinicians no longer have to choose between preventing infection or preventing blocked lines. Protect patients from infection TauroLock-U25.000 is an antimicrobial CLS containing taurolidine, which provides added protection by killing bacteria and funghi within 2 hours of locking. TauroLock-U25.000 will also aid in preventing biofilm formation in the line. 2
Prevent blocked lines TauroLock-U25.000 contains urokinase (25.000 IU), a thrombolytic agent which aids in the prevention of blocked lines, and subsequent catheter dysfunction. 1
Cost savings with TauroLock-U25000 A signifcant catheter-related cost reduction using TauroLock-U25.000 has been demonstrated in a 2017 study. 1 The catheter-related combined yearly expenses, including costs for CLS and treatment of complications associated with CRI and catheter dysfunction were shown to be 43% lower in the group where patients’ lines were locked once a week with TauroLock-U25.000.
Contact marketing@kimal.co.uk to learn more about reducing patient risk and improving cost efficiencies with TauroLock-U25.000. 1. Winnicki, W., Herkner, H., Lorenz, M., Handisurya, A. (2017) Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney International 93(3). | 2. Jimenez Hernández, M., Soriano, A., Filella, X., Calvo, M., Coll, E., Rebled, J.M., Poch, E., Graterol, F., Compte, M.T., Maduell, F., Fontsere, N. (2020) Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation. The Journal of Vascular Access.
DCR1683 REV. 1 | AUGUST 2020